Your browser doesn't support javascript.
loading
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.
Ilié, Marius; Beaulande, Mélanie; Ben Hadj, Saima; Chamorey, Emmanuel; Schiappa, Renaud; Long-Mira, Elodie; Lassalle, Sandra; Butori, Catherine; Cohen, Charlotte; Leroy, Sylvie; Guérin, Olivier; Mouroux, Jérôme; Marquette, Charles-Hugo; Pomerol, Jean-François; Erb, Gilles; Hofman, Véronique; Hofman, Paul.
Afiliação
  • Ilié M; Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, CHU Nice, FHU OncoAge, Pasteur Hospital, 06000 Nice, France. ilie.m@chu-nice.fr.
  • Beaulande M; CNRS, INSERM, IRCAN, FHU OncoAge, Université Côte d'Azur, Team 4, 06000 Nice, France. ilie.m@chu-nice.fr.
  • Ben Hadj S; Hospital-Integrated Biobank (BB-0033-00025), CHU Nice, FHU OncoAge, Université Côte d'Azur, 06000 Nice, France. ilie.m@chu-nice.fr.
  • Chamorey E; EMEA-LATAM Division, Roche Diagnostics France, 38240 Meylan, France. melanie.beaulande@roche.com.
  • Schiappa R; Imaging Analysis, Tribvn Healthcare, 92320 Châtillon, France. sbenhadj@tribvn-hc.com.
  • Long-Mira E; Biostatistics Unit, FHU OncoAge, Antoine Lacassagne Comprehensive Cancer Center, 06189 Nice, France. emmanuel.chamorey@nice.unicancer.fr.
  • Lassalle S; Biostatistics Unit, FHU OncoAge, Antoine Lacassagne Comprehensive Cancer Center, 06189 Nice, France. Renaud.SCHIAPPA@nice.unicancer.fr.
  • Butori C; Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, CHU Nice, FHU OncoAge, Pasteur Hospital, 06000 Nice, France. long-mira.e@chu-nice.fr.
  • Cohen C; CNRS, INSERM, IRCAN, FHU OncoAge, Université Côte d'Azur, Team 4, 06000 Nice, France. long-mira.e@chu-nice.fr.
  • Leroy S; Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, CHU Nice, FHU OncoAge, Pasteur Hospital, 06000 Nice, France. lassalle.s@chu-nice.fr.
  • Guérin O; CNRS, INSERM, IRCAN, FHU OncoAge, Université Côte d'Azur, Team 4, 06000 Nice, France. lassalle.s@chu-nice.fr.
  • Mouroux J; Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, CHU Nice, FHU OncoAge, Pasteur Hospital, 06000 Nice, France. butori.c@chu-nice.fr.
  • Marquette CH; Department of Thoracic Surgery, FHU OncoAge, CHU Nice, Université Côte d'Azur, 06000 Nice, France. cohen.c@chu-nice.fr.
  • Pomerol JF; Department of Pulmonary Medicine and Thoracic Oncology, Pasteur Hospital, Université Côte d'Azur, CHU Nice, FHU OncoAge, 06000 Nice, France. leroy.s2@chu-nice.fr.
  • Erb G; Department of Geriatric Medicine, Cimiez Hospital, Université Côte d'Azur, CHU Nice, FHU OncoAge, 06000 Nice, France. guerin.o@chu-nice.fr.
  • Hofman V; Department of Thoracic Surgery, FHU OncoAge, CHU Nice, Université Côte d'Azur, 06000 Nice, France. mouroux.j@chu-nice.fr.
  • Hofman P; Department of Pulmonary Medicine and Thoracic Oncology, Pasteur Hospital, Université Côte d'Azur, CHU Nice, FHU OncoAge, 06000 Nice, France. marquette.c@chu-nice.fr.
Cancers (Basel) ; 10(9)2018 Sep 13.
Article em En | MEDLINE | ID: mdl-30216999
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França